1997
DOI: 10.1097/00008877-199708000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
19
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 0 publications
1
19
0
Order By: Relevance
“…social interaction test: Kennedy et al 1993;elevated plus-maze: Fone et al 1996; canopy stretched attend posture test: Grewal et al 1997). Correspondingly, Meert et al (1997) have found that mCPP treated animals appear to be generally aroused, as evidenced by a doserelated increase in plasma prolactin and ACTH levels, in spite of a decrement in locomotor performance.…”
Section: Effects Of Yohimbine On Ueepm Behaviourmentioning
confidence: 97%
“…social interaction test: Kennedy et al 1993;elevated plus-maze: Fone et al 1996; canopy stretched attend posture test: Grewal et al 1997). Correspondingly, Meert et al (1997) have found that mCPP treated animals appear to be generally aroused, as evidenced by a doserelated increase in plasma prolactin and ACTH levels, in spite of a decrement in locomotor performance.…”
Section: Effects Of Yohimbine On Ueepm Behaviourmentioning
confidence: 97%
“…The agonists MK212 and mCPP are pharmacological tools that possess nanomolar affinity for 5-HT 2C receptors and approximately five-to 16-fold selectivity for 5-HT 2C receptors over other 5-HT receptors (Hoyer 1988b;Kennett et al 1994a;Porter et al 1999). MK212 is a full agonist, and mCPP is a partial agonist at 5-HT 2C receptors in behavioral assays, and both MK212 and mCPP are used frequently to investigate the functional consequence of the 5-HT 2C receptor activation (Cunningham et al 1986;Fiorella et al 1995a, b;Kennett and Curzon 1988;McCreary et al 2003;Meert et al 1997). Therefore, to further characterize the receptor pharmacology of MK212 and mCPP in rats, the nonselective 5-HT 2C receptor antagonists, metergoline, mianserin, methysergide, cyproheptadine and BOL, the 5HT 2A/2C receptor antagonist ketanserin, the 5HT 2B receptor antagonist SB 204,741, the 5HT 2B/2C receptor antagonist SB 200,646, and the peripherally acting 5-HT 2C receptor antagonist RS102221 were evaluated for their capacity to competitively antagonize MK212 and mCPP in a schedule-controlled responding assay.…”
mentioning
confidence: 99%
“…These studies will provide a comparison to the 5-HT 2C receptor antagonist potencies reported in previous studies. Indeed, a characteristic of the 5-HT 2C receptor agonists such as mCPP is a pronounced inhibitory influence on locomotor function, which is blocked by antagonists with an affinity for 5-HT 2C receptors such as SB 200,646, mianserin, and methysergide (Kennett et al 1994b;Meert et al 1997). The characterization of the unique behavioral interaction of drugs with 5HT 2C receptors is a crucial element in the understanding of their pharmacological actions.…”
mentioning
confidence: 99%
“…[6][7][8][9][10][11][12] One enantiomer within this isoxazolidine series, R107500, was selected for clinical evaluation as an anxiolytic agent.…”
mentioning
confidence: 99%
“…[1][2][3][4][5] Some of those tetracyclic isoxazolidines/tetrahydrofurans were potent mCPP (m-chlorophenylpiperazine) antagonists as shown in our in vivo mCPP challenge test, [3][4][5] and therefore could be considered as potential anxiolytic/antidepressants. [6][7][8][9][10][11][12] One enantiomer within this isoxazolidine series, R107500, was selected for clinical evaluation as an anxiolytic agent.…”
mentioning
confidence: 99%